Abstract
Background:The Intergroup Melanoma Surgical Trial began in 1983 to examine the optimal surgical margins of excision for primary melanomas of intermediate thickness (i.e., 1–4 mm). There is now a median 10-year follow-up.
Methods:There were two cohorts entered into a prospective multi-institutional trial: (1) 468 patients with melanomas on the trunk or proximal extremity who randomly received a 2 cm or 4 cm radial excision margin and (2) 272 patients with melanomas on the head, neck, or distal extremities who received a 2 cm radial excision margin.
Results:A local recurrence (LR) was associated with a high mortality rate, with a 5-year survival rate of only 9% (as a first relapse) or 11% (anytime) compared with an 86% survival for those patients who did not have a LR (P < .0001). The 10-year survival for all patients with a LR was 5%. The 10-year survival rates were not significantly different when comparing 2 cm vs. 4 cm margins of excision (70% vs. 77%) or comparing the management of the regional lymph nodes (observation vs. elective node dissection). The incidences of LR were the same for patients having a 2 cm vs. 4 cm excision margin regardless of whether the comparisons were made as first relapse (0.4% vs. 0.9%) or at anytime (2.1% vs. 2.6%). When analyzed by anatomic site, the LR rates were 1.1% for melanomas arising on the proximal extremity, 3.1% for the trunk, 5.3% for the distal extremities, and 9.4% for the head and neck. The most profound influence on LR rates was the presence or absence of ulceration; it was 6.6% vs. 1.1% in the randomized group involving the trunk and proximal extremity and was 16.2% vs. 2.1% in the non-randomized group involving the distal extremity and head and neck (P < .001). A multivariate (Cox) regression analysis showed that ulceration was an adverse and independent factor (P = .0001) as was head and neck melanoma site (P = .01), while the remaining factors were not significant (all with P > .12).
Conclusion:For this group of melanoma patients, a local recurrence is associated with a high mortality rate, a 2-cm margin of excision is safe and ulceration of the primary melanoma is the most significant prognostic factor heralding an increased risk for a local recurrence.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Milton GW, Shaw HM, Farago GA, McCarthy WH. Tumor thickness and the site and time of first recurrence in cutaneous malignant melanoma (stage I). Br J Surg 1980; 67: 543–546.
Roses DF, Harris MN, Rigel D, Carrey Z, Friedman R, Kopf AW. Local and in-transit metastases following definitive excision for primary cutaneous malignant melanoma. Ann Surg 1983; 198: 65.
Urist MM, Balch CM, Soong SJ, Shaw HM, Milton GW, Maddox WA. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3,445 patients with primary cutaneous melanoma. Cancer 1985; 55: 1398–1402.
Dong XD, Tyler D, Johnson JL, DeMatos P, Seigler HF. Analysis of prognosis and disease progression after local recurrence of melanoma. Cancer 2000; 88: 1063–71.
Breslow A, Macht SD. Optimal size of resection margin for thin cutaneous melanoma. Surg Gynecol Obstet 1977; 145: 691–692.
Balch CM, Murad TM, Soong SJ, Ingalls AL, Richards PC, Maddox WA. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer 1979; 43: 883–8.
Cascinelli N, Van Der Esch EP, Breslow A, et al. The problem of resection margins. Eur J Cancer 1980; 16: 1079.
8. Elder DE, Guerry D, Heiberger RM, LaRossa D, Goldman LI, ClarkWHJr. Optimal resection margins for cutaneous malignant melanoma. Plast Reconstr Surg 1983; 71: 66–72.
Veronesi U, Cacinelli N, Adamus J, et al. Thin stage primary cutaneous malignant melanoma: Comparison of excision with margins of 1 to 3 cm N Engl J Med 1988; 318: 1159–62.
Veronesi U, Cascinelli N. Narrow excision (1-cm margin): A safe procedure for thin cutaneous melanoma. Arch Surg 1991; 126: 438–41.
11. Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996; 224: 255–63.
Balch CM, SoongS-J, Ross MI, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 2000; 7: 87–97.
Balch CM, Urist MM, Karakousis CP, et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg 1993; 218: 262–7.
Karakousis CP, Balch CM, Urist MM, Ross MM, Smith TJ, Bartolucci AA. Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial. Ann Surg Oncol 1996; 3: 446–452.
Zelen M. A new design for randomized clinical trials. N Engl J Med 1979; 300: 1242–1245.
Ringborg U, Andersson R, Eldh J, et al. Resection margins of 2 versus 5 cm for cutaneous melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group. Cancer 1996; 77: 1809–14.
Khayat D. ASCO abstract on French Cooperative Study. ASCO Abstract.
Balch CM, Murad TM, Soong SJ, Ingalls AL, Halpern NB, Maddox WA. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark’s and Breslow’s staging methods. Ann Surg 1978; 188: 732–42.
Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery 1979; 86: 343–51.
Balch CM, Wilkerson JA, Murad TM, Soong SJ, Ingalls AL, Maddox WA. The prognostic significance of ulceration of cutaneous melanoma. Cancer 1980; 45: 3012–17.
Balch CM, Soong SJ, Milton GW, et al. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 1982; 196: 677–84.
Cascinelli N, Marubini E, Morabito A, Bufalino R. Prognostic factors for stage I melanoma of the skin: a review. Stat Med 1985; 4: 265–78.
Elberg JJ, Poulsen H, Ladefoged C. The influence of resection margin on prognosis in clinical Stage I malignant melanoma of the lower leg. Scand J Plast Reconstr Surg Hand Surg 1989; 23: 59–63.
Balch CM Cutaneous melanoma: prognosis and treatment results worldwide. Semin Surg Oncol 1992; 8: 400–14.
Cruse CW, Wells KE, Schroer KR, Reintgen DS. Etiology and prognosis of local recurrence in malignant melanoma of the skin. Ann Plast Surg 1992; 28: 26–28.
Heaton KM, Sussman JJ, Gershenwald JE, Lee JE, Reintgen DS, Mansfield PF, Ross MI. Surgical margins and prognostic factors in patients with thick (>4.0 mm) primary melanoma. Ann Surg Oncol 1998; 5: 322–328.
Urist MM, Balch CM, Soong S, et al. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment. Ann Surg 1984; 200: 769–75.
O’Brien CJ, Coates AS, Petersen-Schaefer K, et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 1991; 162: 310–14.
AFisher SR, O’Brien CJ. Head and Neck Melanoma. In: Balch CM, Houghton AN, Sober AJ, Soong S, eds. Cutaneous Melanoma 3rd edition. St. Louis, MO. Quality Medical Publishers, 1998: 163–74.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Balch, C.M., Soong, Sj., Smith, T. et al. Long-Term Results of a Prospective Surgical Trial Comparing 2 cm vs. 4 cm Excision Margins for 740 Patients With 1–4 mm Melanomas. Ann Surg Oncol 8, 101–108 (2001). https://doi.org/10.1007/s10434-001-0101-x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10434-001-0101-x